Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1969-3-18
pubmed:abstractText
Vancomycin and ristocetin formed complexes on being mixed with mucopeptide precursors from various bacteria, as shown by chromatography, electrophoresis and differential ultraviolet spectra. Equimolar proportions of antibiotic and peptide were present. The specificity of the reaction was studied and the smallest molecule found to react was acetyl-d-alanyl-d-alanine. This C-terminal dipeptide sequence must be present for complex-formation; change of configuration or esterification prevented it. Modified vancomycins that retained antibiotic activity also combined with appropriate peptides. The dissociation constants of the more stable complexes were estimated from the differential-absorption results. The relationship of complex-formation to antibiotic action is discussed. Penicillin, supposed to be an analogue of acyl-d-alanyl-d-alanine, also modified the spectrum of vancomycin; so, too, did sodium benzylpenicilloate.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-13198859, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-13271455, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-13425452, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-13998579, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-14150645, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-14287259, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-14324547, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-14491721, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-14941086, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-16748273, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-4871205, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-4871206, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-4955576, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-4963467, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-5219821, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-5329013, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-5653196, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-5721469, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-5721471, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-5967114, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-5971843, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-6027793, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-6027794, http://linkedlifedata.com/resource/pubmed/commentcorrection/5763787-6056843
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:volume
111
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
195-205
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1969
pubmed:articleTitle
Specificity of combination between mucopeptide precursors and vancomycin or ristocetin.
pubmed:publicationType
Journal Article